Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amar Harry Kelkar, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Cornell University College of Agriculture and Life Sciences, Ithaca, NYBS05/2010Biological Sciences, Genetics & Development
St. George's University School of Medicine, True Blue, Grenada, WIMD05/2015Doctor of Medicine
University of Illinois College of Medicine, Peoria, IL06/2018Residency in Internal Medicine
University of Florida College of Medicine, Gainesville, FL06/2021Fellowship in Hematology & Oncology
Harvard T.H. Chan School of Public Health, Boston, MA08/2021Program in Clinical Effectiveness
Dana-Farber Cancer Institute, Boston, MA08/2022Advanced Fellowship in Stem Cell Transplantation
Harvard T.H. Chan School of Public Health, Boston, MAMPH11/2023Clinical Effectiveness
2022
ASCO Annual Meeting Merit Award Recipient

Overview
Dr. Amar Kelkar is a Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. His is a member of the Abel Laboratory with research interests are in hematology, care delivery, cost-effectiveness, medical ethics, and health policy. He is also MPH candidate at the Harvard T.H. Chan School of Public Health.

His background is in molecular biology and genetics with a degree from Cornell University in Biological Sciences, where he worked for 3 years as a member of the Andrew Clark Laboratory focused on population genetics. He completed postgraduate medical training at the University of Illinois College of Medicine at Peoria, the University of Florida College of Medicine, and the Dana-Farber Cancer Institute.

He also has interests in health policy and medical advocacy and serves on the American Society of Hematology Committee on Practice and Subcommittee on Reimbursement, the American Society for Transplantation and Cellular Therapy Value and Health Economics Special Interest Group, and the Massachusetts Medical Society (MMS) Committee on Publications that oversees the NEJM Group. He previously served on the MMS Board of Trustees, the American Medical Association (AMA) Council on Legislation, and was the AMA Resident and Fellow Section Governing Council Delegate to the House of Delegates.

Research
The clinical trials listed below are automatically derived from ClinicalTrials.gov and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
NCT Short Title Overall Status Start Completion

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sawalha L, Kelkar AH, Mohyuddin GR, Goodman AM, Gagelmann N, Al Hadidi S. Analysis of repeated roles in editorial boards at oncology focused journals. J Cancer Policy. 2022 Dec 17; 35:100380. PMID: 36538988.
    Citations:    Fields:    
  2. Cliff ERS, Kelkar AH. Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease-Estimating the True Value. JAMA Neurol. 2022 Oct 03. PMID: 36190718.
    Citations:    Fields:    
  3. Fatoki RA, Koehn K, Kelkar A, Al Hadidi S, Mehra N, Mian H, Landgren O, Kazandjian D, Hoffman J, Sborov DW, Mohyuddin GR. Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies. JCO Glob Oncol. 2022 08; 8:e2200119. PMID: 35960904; PMCID: PMC9470137.
    Citations:    Fields:    Translation:Humans
  4. Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, Panch S, Confer D, Liu H, Badawy SM, Beitinjaneh A, Diaz MA, Hildebrandt GC, Kelkar AH, Lazarus HM, Murthy HS, Preussler JM, Schears RM, Sharma A, van der Poel M, Bruce JG, Pulsipher MA, Shaw BE, Wingard JR, Switzer GE. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials. Transplant Cell Ther. 2022 09; 28(9):603.e1-603.e7. PMID: 35688325; PMCID: PMC9427696.
    Citations:    Fields:    
  5. Amonoo HL, Harnedy LE, Deary EC, Traeger L, Brown LA, Daskalakis EP, Cutler C, Kelkar AH, Rosales R, Goldschen L, Pirl WF, Feig EH, Revette A, Lee SJ, Huffman JC, El-Jawahri A. Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study. Bone Marrow Transplant. 2022 08; 57(8):1277-1286. PMID: 35589998; PMCID: PMC9119381.
    Citations:    Fields:    
  6. Bloom MD, Saker H, Glisch C, Ramnaraign B, George TJ, Markham MJ, Kelkar AH. Administration of Immune Checkpoint Inhibitors Near the End of Life. JCO Oncol Pract. 2022 06; 18(6):e849-e856. PMID: 35254868.
    Citations:    Fields:    Translation:Humans
  7. Fragner M, Imbo B, Hobson J, Roberts JC, Rajasekhar A, Tarantino MD, Morell J, Kelkar AH. Time is Blood: The Impact of Diagnostic Delays on Acquired Hemophilia A. Cureus. 2022 Feb; 14(2):e22048. PMID: 35340501; PMCID: PMC8915674.
    Citations:    
  8. Kelkar AH, Zhao J, Wang S, Cogle CR. Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare (Basel). 2022 Jan 29; 10(2). PMID: 35206878; PMCID: PMC8871935.
    Citations:    
  9. Banerjee R, Midha S, Kelkar AH, Goodman A, Prasad V, Mohyuddin GR. Synthetic control arms in studies of multiple myeloma and diffuse large B-cell lymphoma. Br J Haematol. 2022 03; 196(5):1274-1277. PMID: 34750805.
    Citations:    Fields:    Translation:Humans
  10. De Filippis S, Moore C, Ezell K, Aggarwal K, Kelkar AH. Immune Checkpoint Inhibitor-Associated Thrombotic Thrombocytopenic Purpura in a Patient With Metastatic Non-Small-Cell Lung Cancer. Cureus. 2021 Jun; 13(6):e16035. PMID: 34345535.
    Citations: 2     
  11. Turcotte ME, Kelkar AH, Chaffin J, Dang NH. Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic Immunosuppression. Cureus. 2021 May 02; 13(5):e14808. PMID: 34094764.
    Citations:    
  12. Sorrentino AD, Kelkar AH, Dang NH. Diffuse Large B-Cell Lymphoma Presenting as an Unusual Paraneoplastic Neurologic Syndrome Affecting the Central and Peripheral Nervous Systems. Cureus. 2021 Apr 20; 13(4):e14590. PMID: 34036008.
    Citations:    
  13. Banerjee R, Kelkar AH, Logan AC, Majhail NS, Pemmaraju N. The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond. Curr Hematol Malig Rep. 2021 04; 16(2):132-139. PMID: 33788125.
    Citations:    Fields:    Translation:Humans
  14. Kelkar AH, Blake JA, Cherabuddi K, Cornett H, McKee BL, Cogle CR. Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar. Healthcare (Basel). 2021 Mar 19; 9(3). PMID: 33808758.
    Citations: 22     
  15. Kopparthy P, Kelkar AH, Aggarwal K, De Filippis S, Fletcher B. Red Blood Cell Exchange in a Patient With Extramedullary Hematopoiesis and Cor Pulmonale Secondary to Beta Thalassemia. Cureus. 2021 Mar 01; 13(3):e13638. PMID: 33824791; PMCID: PMC8011980.
    Citations: 1     
  16. Culpepper T, Kelkar AH. Undiagnosed Wilson's Disease and Fibromyalgia Masking Bowel Perforation. Cureus. 2021 Feb 23; 13(2):e13504. PMID: 33786213.
    Citations:    
  17. Kelkar AH, Loc BL, Tarantino MD, Rajasekhar A, Wang H, Kelkar M, Farrell J. Cytomegalovirus-Associated Venous and Arterial Thrombotic Disease. Cureus. 2020 Dec 18; 12(12):e12161. PMID: 33489573.
    Citations: 2     
  18. Kelkar AH, Rajasekhar A. Do prophylactic inferior vena cava filters in trauma patients reduce the risk of mortality or pulmonary embolism? Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):629-633. PMID: 33275719.
    Citations: 1     Fields:    Translation:Humans
  19. Kelkar AH, Rajasekhar A. Inferior vena cava filters: a framework for evidence-based use. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):619-628. PMID: 33275716.
    Citations: 2     Fields:    Translation:Humans
  20. Minish JM, Hamed N, Seifert R, Kelkar AH. T-Cell Large Granular Lymphocytic Leukemia as a Cause for Severe Neutropenia. Cureus. 2020 Sep 01; 12(9):e10186. PMID: 33029465.
    Citations: 1     
  21. Kelkar AH, Cogle CR. Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of Care. Healthcare (Basel). 2020 Jul 17; 8(3). PMID: 32708922.
    Citations:    
  22. Minish JM, Kelkar AH, Mehta AR, Gaffar M, Dang NH. Intravascular Large B-Cell Lymphoma Presenting as Acute Axonal Polyneuropathy: A Case Report and Literature Review. J Investig Med High Impact Case Rep. 2020 Jan-Dec; 8:2324709620959997. PMID: 32935589.
    Citations: 2     Fields:    Translation:Humans
  23. Kelkar AH, Tarantino MD, Roberts JC. Synthetic Cannabinoid-Associated Coagulopathy. N Engl J Med. 2019 01 03; 380(1):101-102. PMID: 30601754.
    Citations: 1     Fields:    Translation:Humans
  24. Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC. An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois. N Engl J Med. 2018 09 27; 379(13):1216-1223. PMID: 30280655.
    Citations: 20     Fields:    Translation:Humans
  25. Kelkar AH, Jacob KS, Yousif EB, Farrell JJ. Venous thromboembolism related to cytomegalovirus infection: A case report and literature review. Medicine (Baltimore). 2017 Dec; 96(51):e9336. PMID: 29390512; PMCID: PMC5758214.
    Citations: 2     Fields:    Translation:Humans
  26. Kelkar AH, Crabb JE, Pflederer BR. Unusual association of ADPKD and bullous emphysema: a case report and literature review. Clin Nephrol. 2017 10; 88(10):226-228. PMID: 28862130.
    Citations:    Fields:    
  27. Kelkar AH, Shah AA, Yong SL, Ahmed Z. An unusual association between hemophagocytic lymphohistiocytosis, mixed connective tissue disease, and autoimmune hemolytic anemia: A case report. Medicine (Baltimore). 2017 Jul; 96(28):e7488. PMID: 28700492; PMCID: PMC5515764.
    Citations: 2     Fields:    Translation:Humans
  28. Kandula M, Kelkar AH, Liberio N, Aiyer MK. Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis. J Community Hosp Intern Med Perspect. 2016; 6(6):33383. PMID: 27987289; PMCID: PMC5161803.
    Citations: 2     
  29. Meeker JW, Kelkar AH, Loc BL, Lynch TJ. A Case Report of Delayed Return of Spontaneous Circulation: Lazarus Phenomenon. Am J Med. 2016 Dec; 129(12):e343-e344. PMID: 27491467.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kelkar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.